Defective inter-domain interaction within the ryanodine receptor plays a key role in the pathogenesis of heart failure

被引：0
|
作者：
Yano, M [1 ]
机构：
[1] Yamaguchi Univ, Grad Sch Med, Dept Med Bioregulat, Div Cardiovasc Med, Yamaguchi, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2005年 / 11卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2005.08.073
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S257 / S257
页数：1
相关论文
共 50 条
  • [21] Defective Interdomain Interaction Within the Ryanodine Receptor as a Common Cause of Heart Failure and Lethal Arrhythmia
    Uchinoumi, Hitoshi
    Yano, Masafumi
    Suetomi, Takeshi
    Ohno, Makoto
    Xu, Xiaojuan
    Tateishi, Hiroki
    Okuda, Shinichi
    Kobayashi, Shigeki
    Yamamoto, Takeshi
    Ikeda, Yasuhiro
    Matsuzaki, Masunori
    CIRCULATION RESEARCH, 2008, 103 (05) : E50 - E50
  • [22] Dantrolene Inhibits Spontaneous Ca2+ Release as a Substrate for Catecholaminergic Polymorphic Ventricular Tachycardia (PSVT) by Correcting Defective Inter-Domain Interaction Within the Ryanodine Receptor
    Kobayashi, Shigeki
    Yano, Masafumi
    Suetomi, Takeshi
    Ono, Makoto
    Xu, Xiaojuan
    Uchinoumi, Hitoshi
    Tateishi, Hiroki
    Okuda, Shinichi
    Yamamoto, Takeshi
    Matsuzaki, Masunori
    CIRCULATION, 2008, 118 (18) : S921 - S921
  • [23] A variably spliced region in the type 1 ryanodine receptor may participate in an inter-domain interaction
    Kimura, Takashi
    Pace, Suzy M.
    Wei, Lan
    Beard, Nicole A.
    Dirksen, Robert T.
    Dulhunty, Angela F.
    BIOCHEMICAL JOURNAL, 2007, 401 (01) : 317 - 324
  • [24] Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure
    Yano, M
    Okuda, S
    Oda, T
    Tokuhisa, T
    Tateishi, H
    Mochizuki, M
    Noma, T
    Doi, M
    Kobayashi, S
    Yamamoto, T
    Ikeda, Y
    Ohkusa, T
    Ikemoto, N
    Matsuzaki, M
    CIRCULATION, 2005, 112 (23) : 3633 - 3643
  • [25] Neomycin, ryanodine receptor channel blocker, stabilizes inter-domain interactions of domain switch
    Hamada, T
    Kobayashi, S
    Ikemoto, N
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 484A - 484A
  • [26] Type 2 Ryanodine Receptor Hyperphosphorylation Plays a Role in the Development of Hypertensive Heart Failure
    Chen, Kangyin
    Huang, Tigang
    Liu, Tong
    Li, Yong-Jian
    Zhou, Xin
    Cai, Wei
    Li, Guangping
    Li, Yuming
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C57 - C58
  • [27] Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction
    Xu, Xiaojuan
    Yano, Masafumi
    Uchinoumi, Hitoshi
    Hino, Akihiro
    Suetomi, Takeshi
    Ono, Makoto
    Tateishi, Hiroki
    Oda, Tetsuro
    Okuda, Shinichi
    Doi, Masahiro
    Kobayashi, Shigeki
    Yamamoto, Takeshi
    Ikeda, Yasuhiro
    Ikemoto, Noriaki
    Matsuzaki, Masunori
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (03) : 660 - 666
  • [28] De-stabilization of inter-domain interactions within the ryanodine receptor type 2 produces hypertrophy in neonatal rat cardiomyocytes
    Hamada, Tomoyo
    Fessenden, James D.
    Nickson, Phil
    Toth, Ambrus
    Shtifman, Alexander
    Erhardt, Peter
    Ikemoto, Noriaki
    BIOPHYSICAL JOURNAL, 2007, : 91A - 91A
  • [29] Tight binding of calmodulin to the cardiac ryanodine receptor may reduce the spontaneous Ca2+ release events induced by mutation-linked, defective inter-domain interaction
    Xu, Xiaojuan
    Yano, Masafumi
    Ohno, Makoto
    Uchinoumi, Hitoshi
    Tateishi, Hiroki
    Kobayashi, Shigeki
    Yamamoto, Takeshi
    Ikeda, Yasuhiro
    Matsuzaki, Masunori
    CIRCULATION, 2007, 116 (16) : 186 - 186
  • [30] The cardiac ryanodine receptor (calcium release channel): Emerging role in heart failure and arrhythmia pathogenesis
    Scoote, M
    Williams, AJ
    CARDIOVASCULAR RESEARCH, 2002, 56 (03) : 359 - 372
12345